Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
The availability of compounded semaglutide has been one of the most significant developments in the GLP-1 space — making medications that were financially out of reach for most people accessible at a fraction of the cost. Here is an honest, detailed comparison.
What Is Compounded Semaglutide?
Compounded semaglutide is manufactured by licensed compounding pharmacies using pharmaceutical-grade semaglutide API (active pharmaceutical ingredient) — the same molecule as in Ozempic and Wegovy. Compounding pharmacies are permitted to produce medications that are equivalent to FDA-approved drugs when those drugs are on shortage or when a patient has a specific medical need. Semaglutide has been on FDA shortage status since 2022, which legally permits compounding.
The Cost Comparison
| Product | Monthly Cost | Form | FDA Approval |
|---|---|---|---|
| Wegovy (brand) | ~$1,350/mo | Pre-filled pen | ✓ Yes |
| Ozempic (brand) | ~$1,000/mo | Pre-filled pen | ✓ Yes (diabetes) |
| Compounded (telehealth) | $149–$350/mo | Vial + syringe | ✗ Not as product |
What You Give Up With Compounded
Pre-filled pen convenience: Brand Ozempic and Wegovy come in pre-filled, dose-dialling pens — much simpler for injection. Compounded semaglutide requires drawing up a dose from a multi-dose vial with a separate insulin syringe. This is straightforward with a brief learning curve but is an extra step.
FDA approval as a finished product: The compounded product itself is not FDA-approved, though the API must be pharmaceutical grade. This is a regulatory distinction, not necessarily a safety distinction when dealing with reputable compounders.
Brand recognition and standardisation: Each batch from a compounding pharmacy is slightly different from the last — minor variation in concentration is possible. Brand products have tighter manufacturing tolerances.
How to Verify Pharmacy Quality
The key safety question with compounded semaglutide is pharmacy quality. Verify: the pharmacy holds 503A or 503B FDA registration (503B = stricter standards, outsourcing facility); sources API from FDA-registered API manufacturers; provides certificates of analysis for each batch; your telehealth platform publicly discloses which pharmacy partners they use. Most reputable telehealth platforms (including Direct Meds) vet their compounding partners and will share this information.
The FDA Shortage Status Situation
In 2024, Novo Nordisk declared the semaglutide shortage resolved for certain doses. The FDA subsequently indicated compounders may need to wind down production. This situation is evolving — check current status with your provider. As of early 2026, compounded semaglutide remains widely available through telehealth platforms.
Frequently Asked Questions
Q: Is compounded semaglutide the same as Ozempic?
A: Compounded semaglutide contains the same active molecule — semaglutide — as Ozempic and Wegovy. It is not FDA-approved as a finished product but is manufactured by FDA-registered 503A/503B compounding pharmacies. The main differences: no brand patent protection (much lower cost), comes as a multi-dose vial requiring self-injection with a separate syringe rather than a pre-filled pen, and may contain additives like B12 or NAD+.
Q: Is compounded semaglutide safe?
A: Compounded semaglutide from a legitimate FDA-registered 503B compounding pharmacy using pharmaceutical-grade active pharmaceutical ingredient (API) has a good safety record. The FDA has issued warnings about unregistered compounders using non-pharmaceutical grade API. Risks are primarily about pharmacy quality rather than the molecule itself. Always verify your pharmacy is FDA-registered (503A or 503B) and your provider vets their pharmacy supply chain.
Q: How much cheaper is compounded semaglutide?
A: Brand Wegovy lists at approximately $1,350/month. Brand Ozempic at approximately $1,000/month (for diabetes indication). Compounded semaglutide through telehealth platforms typically ranges from $149–$350/month depending on dose and provider. The cost difference is 60–85% — compounded semaglutide is dramatically less expensive.
📖 Further Reading
Access Compounded Semaglutide From $149/Month
Physician-supervised. Ships to most US states.
Sponsored | Affiliate link
Affiliate disclosure: This article contains affiliate links. See our Affiliate Disclosure.
Sources & References
- U.S. Food and Drug Administration (FDA) – Drug Approvals and Databases
- National Institutes of Health (NIH) – PubMed Medical Literature
- American Diabetes Association – Medication & Therapies
- Novo Nordisk – Clinical Research Data
- Eli Lilly – Medical Information
This content is regularly reviewed and updated to reflect the latest medical research and FDA guidance.